(Q43299262)
Statements
1 reference
Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma (English)
1 reference
Bernard Escudier
1 reference
Nicholas J Vogelzang
1 reference
Jan Roigas
1 reference
Silke Gillessen
1 reference
Ulrika Harmenberg
1 reference
Sandhya Srinivas
1 reference
Sasja F Mulder
1 reference
George Fountzilas
1 reference
Christian Peschel
1 reference
Per Flodgren
1 reference
Edna Chow Maneval
1 reference
Isan Chen
1 reference
3 August 2009
1 reference
1 reference
27
1 reference
25
1 reference
4068-4075
1 reference
Identifiers
1 reference
1 reference